http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
조요한(Yo Han Joh),최인실(In Sil Choi),이근욱(Keun Wook Lee),오도연(Do Youn Oh),김병수(Byung Su Kim),이대호(Dae Ho Lee),김태유(Tae You Kim),방영주(Yung Jue Bang),우홍균(Hong Gyun Wu),성명훈(Myung Whun Sung),이철희(Chul Hee Lee),김광현(N 대한두경부종양학회 2001 대한두경부 종양학회지 Vol.17 No.2
Objective: The role of chemotherapy in locally advanced head and neck cancer has been established in nasopharynx and larynx as definitive therapy and organ preserving therapy, respectively. Oral cavity cancers are relatively uncommon and local recurrence is the main cause of treatment failure. We planned this retrospective study to evaluate the role of neoadjuvant chemotherapy in locally advanced oral cavity cancer patients. Materials and Methods: From 1988 March to 2001 February, locally advanced, previously untreated oral cavity cancer patients who received neoadjuvant chemotherapy were examined. Chemotherapy had been done in the following patients: Histologically proven squamous cell or poorly differentiated carcinoma, stage 3 or 4, and performance state 0-2 patients. Chemotherapy regimen consisted of cisplatin and infusional 5-fluorouracil. Response was evaluated after 2 cycles and in case of no response, definitive local therapy was done; otherwise 3 cycles was done before local treatment. Results: 48 patients were treated and 47 patients were evaluable for responses. Complete response rate was 6.4%(3/47) and partial response 80.0%(38/47), scoring overall response rate of 87.2%. Median time to progression was 27.0 months (95% CI : 0-58months) and overall 5 year survival was 54.8%. 5-year disease-free survival in the patients in remission after local treatment was 51.9%. In multivariate analysis, contributing factor to the survival were response to neoadjuvant chemotherapy and local treatment modalities. Extensive surgery was done in 10 patients and 25 patents (52.1%) was followed up with preserved function. With median follow-up of 57.0 months, 19 recurrences were detected, most of which were local or regional type. Conclusion: Neoadjuvant chemotherapy followed by local treatment in oral cavity cancer showed high response rate and was thought to be effective therapeutic approach especially in view of organ preservation.
증례 : 혈액종양 ; 젊은 여성의 유방에 발생한 원발성 활막 육종 1예
김지원 ( Ji Won Kim ),권지현 ( Ji Hyun Kwon ),오도연 ( Do Youn Oh ),조나리야 ( Nariya Cho ),임석아 ( Seock Ah Im ),김영태 ( Young Tae Kim ),박인애 ( In Ae Park ) 대한내과학회 2010 대한내과학회지 Vol.78 No.5
활막 육종은 주로 관절 주위 조직에 호발하는 악성 종양이다. 종종 관절 이외의 다른 부위에 발생하는 경우도 보고되어있는데, 원발성 유방 활막 육종은 세계적으로도 보고된 예가 드물다. 본 증례는 원발성 유방 활막 육종으로 진단된 15세 여자 환자의 1예이다. 진단 후 유방 종괴에 대한 광범위 절제술을 시행하였으나 9개월 후 국소 재발하였고, 이에재발 부위에 대한 광범위 절제술을 다시 시행하였다. 그러나, 27개월 후 폐의 우상엽에 고립성 폐 전이가 발견되었다. 이에 폐 병변에 대한 절제술 및 고식적 화학요법으로 doxorubicin 및 ifosfamide의 병합 화학요법을 시행하였다. 현재 항암화학요법 종료 후 28개월째 재발의 증거 없이 경과관찰중이다. 이에 저자들은 본 증례를 문헌고찰과 함께 보고하는 바이다. Synovial sarcoma is a malignant soft tissue neoplasm that develops mainly in para-articular locations in the extremities, but can arise in a wide variety of other sites. Primary breast synovial sarcoma has been reported infrequently worldwide. We report the case of 15-year-old female who was diagnosed with primary breast synovial sarcoma. We performed wide excision for the breast mass. However, local recurrence was detected 9 months later. We performed wide excision for the recurrent breast tumor. After 27 months, a solitary metastasis was found in the right upper lobe of the lung. We performed wedge resection for the lung mass and treated her with palliative chemotherapy using doxorubicin and ifosfamide. Twenty-eight months after chemotherapy, she is alive without evidence of recurrence. We report the details of this case along with a review of the literature. (Korean J Med 78:640-644, 2010)
직장암 환자의 수술 전 항암화학방사선치료에서 비적정 항암화학요법의 영향
이지혜(Jihye Lee),강현철(Hyun-Cheol Kang),지의규(Eui Kyu Chie),강경훈(Gyeong Hoon Kang),박재갑(Jae-Gahb Park),오도연(Do-Youn Oh),임석아(Seock-Ah Im),김태유(Tae-You Kim),방영주(Yung-Jue Bang),하성환(Sung Whan Ha) 대한방사선종양학회 2009 Radiation Oncology Journal Vol.27 No.2
목 적: 직장암에서 수술 전 항암화학방사선치료는 수술 후 항암화학방사선치료에 비하여 치료 성적은 비슷하며 독 성은 낮아 최근에 많이 시행되고 있다. 본 연구에서는 수술 전 항암화학방사선치료 시 병행한 항암화학요법 중 적 정 요법과 적정 이하의 비적정 요법에 따른 치료 결과를 알아보고자 하였다. 대상 및 방법: 2003년 4월부터 2006년 4월까지 수술 전 항암화학방사선치료와 수술을 시행한 환자 중 수술 병리결과 확보가 가능하고 단일 제제 화학요법을 시행한 환자 43명을 대상으로 하였다. 방사선치료는 전 골반에 41.4∼50.4 Gy (중앙값, 45 Gy), 종양에 추가조사 0∼5.4 Gy (중앙값, 5.4 Gy), 총 41.4∼50.4 Gy (중앙값, 50.4 Gy)를 시행하였다. 적정군은 5-fluorouracil (5-FU) 500 mg/m2/day를 방사선치료 첫 3일 동안과 5주 후 3일 동안에 반복 급속 정주 한 6명과 경구 capecitabine을 방사선 치료일에 사용한 6명으로 총 12명이었다. 비적정군은 동일량의 5-FU를 방사선치료 첫 3일에만 급속 정주한 31명이었다. 수술은 방사선치료가 끝난 뒤 40∼71일(중앙값, 58일)에시행하였고 36명은 하전방절제술을, 7명은 복회음절제술을 시행하였다.결 과: 적정군과 비적정군 사이에, 치료반응 등급 3 이상의 치료반응(83.3% vs. 67.7%, p=0.456), 수술 전과 비교한 수술 후의 병기하강(75.0% vs. 67.7%, p=0.727), 주변절제연 2 mm 초과의 획득(66.7% vs. 83.9%, p=0.237)등에서 통계적으로 유의하게 차이를 보이지는 않았으나, 병변의 위치가 항문에서 5 cm 이내에 위치한 경우 비적정군에서 괄약근 보존 수술을 시행한 비율이 적정군에 비하여 더 낮은 경향을 보였다(75% vs. 100%, p=0.068). 모든환자에서 3도 이상의 독성은 관찰되지 않았다. 결 론: 비적정군에서 치료에 수반되는 독성은 낮았으나 모두 2도 이하였고, 항문에서 5 cm 이내에 위치한 직장암의 수술 시 괄약근 보존 수술률이 더 낮은 경향을 보여 적정 화학요법의 병행을 시행하는 것이 바람직하겠다. Purpose: To examine the effect of suboptimal chemotherapy in patients undergoing preoperative chemoradiotherapy for the treatment of rectal cancer. Materials and Methods: The medical records of 43 patients who received preoperative concurrent chemoradiotherapy, followed by radical surgery for the treatment of pathologically proven adenocarcinoma of the rectum from April 2003 to April 2006 were retrospectively reviewed. The delivered radiation dose ranged from 41.4 to 50.4 Gy. The standard group consisted of patients receiving two cycles of a 5-FU bolus injection for three days on the first and fifth week of radiotherapy or twice daily with apecitabine. The standard group included six patients for each regimen. The non-standard group consisted of patients receiving one cycle of 5-FU bolus injection for three days on the first week of radiotherapy. The non-standard group included 31 patients. Radical surgery was performed at a median of 58 days after the end of radiotherapy. A low anterior resection was performed in 36 patients, whereas an abdominoperineal resection was performed in 7 patients. Results: No significant difference was observed between the groups with respect to pathologic responses ranging from grades 3 to 5 (83.3% vs. 67.7%, p=0.456), downstaging (75.0% vs. 67.7%, p=0.727), and a radial resection margin greater than 2 mm (66.7% vs. 83.9%, p=0.237). The sphincter-saving surgery rate in low-lying rectal cancers was lower in the non-standard group (100% vs. 75%, p=0.068). There was no grade 3 or higher toxicity observed in all patients. Conclusion: Considering that the sphincter-saving surgery rate in low-lying rectal cancer was marginally lower for patients treated with non-standard, suboptimal chemotherapy, and that toxicity higher than grade 2 was not observed in the both groups, suboptimal chemotherapy should be avoided in this setting.
홍소담 ( So Dam Hong ),신재경 ( Jae Kyoung Shin ),홍희진 ( Hee Jin Hong ),허진형 ( Jin Hyung Heo ),정소영 ( So Young Chong ),오도연 ( Do Youn Oh ),오지수 ( Ji Su Oh ) 대한내과학회 2016 대한내과학회지 Vol.90 No.1
비록 자궁경부암이 갑상선으로의 전이는 매우 드물지만, 자궁경부암의 과거력이 있는 경우, 갑상선부위의 부종이나 촉지되는 결절이 발생하면 반드시 전이성 병변을 의심해봐야 한다. 비록 갑상선으로의 전이는 매우 나쁜 예후를 의미 하지만 고식적 치료로 전신항암요법 및 방사선요법이 환자의 삶의 질 개선에 도움을 줄 수 있다. 드물기는 하지만 갑상선으로의 악성전이 보고가 증가하는 추세로, 이에 대해 어떠한 치료가 가장 효과적일지에 대한 연구가 필요하겠다. Most patients with recurrent uterine cervical cancer have intra-pelvis metastasis with adjacent lymph node involvement, while a lone, distant metastasis is extremely rare. We report a 79-year-old woman with recurrent uterine cervical cancer that presented as thyroid mass with no intra-pelvic recurrence. Four years earlier, the patient had been diagnosed with uterine cervical cancer. She had undergone a course of concurrent chemoradiotherapy to the pelvis and had no subsequent evidence of recurrence. Several weeks before presenting, she had noticed a foreign body sensation in her throat and a palpable mass in the left side of her neck. Clinically, this was metastatic squamous cell carcinoma from the uterine cervix. Patients who present with swelling or palpable nodules in the neck with a previously diagnosed malignancy must be evaluated for metastatic disease, although metastasis from uterine cervical carcinoma to the thyroid gland is rare. (Korean J Med 2016;90:68-71)